You are here: Home / Articles / B Cell-Directed Therapy May Delay RA Development in High-Risk Patients
• By Carina Stanton
Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
Visit the official website for the American College of Rheumatology.